diltiazem has been researched along with phosphatidylcholines in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mason, RP; Moisey, DM; Shajenko, L | 1 |
| Ionov, VA; Siurin, AA | 1 |
| Mason, PE; Mason, RP; Olmstead, EG; Trumbore, MW; Walter, MF | 1 |
| Cheung, GT; Frohlich, J; Lynn, EG; O, K; Siow, YL | 1 |
| Dhalla, NS; Kawabata, K; Nijjar, MS; Okumura, K; Panagia, V; Shah, KR; Tappia, PS | 1 |
| Mahdy, MM; Mokhtar Ibrahim, M; Tawfique, SA | 1 |
6 other study(ies) available for diltiazem and phosphatidylcholines
| Article | Year |
|---|---|
Cholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Cattle; Cell Membrane; Cholesterol; Dihydropyridines; Diltiazem; Electrons; Isradipine; Lipid Bilayers; Myocardium; Nifedipine; Nimodipine; Nitrendipine; Phosphatidylcholines; Rabbits; Verapamil | 1992 |
[The clinical efficacy of diltiazem and the means for enhancing it in treating patients with ischemic heart disease combined with chronic bronchitis].
Topics: Adult; Angina Pectoris; Bronchitis; Chronic Disease; Diltiazem; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Hemodynamics; Humans; Middle Aged; Myocardial Ischemia; Phosphatidylcholines; Respiration | 1993 |
Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine.
Topics: Amlodipine; Antihypertensive Agents; Antioxidants; Calcium; Calorimetry, Differential Scanning; Diltiazem; Dimyristoylphosphatidylcholine; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Inhibitory Concentration 50; Lipid Peroxidation; Phosphatidylcholines; Verapamil | 1999 |
Lipoprotein-X stimulates monocyte chemoattractant protein-1 expression in mesangial cells via nuclear factor-kappa B.
Topics: Amino Acid Sequence; Animals; Calcium Channel Blockers; Cells, Cultured; Chemokine CCL2; Chemotaxis, Leukocyte; Cholesterol; Diglycerides; Diltiazem; Enzyme Inhibitors; Foam Cells; Gene Expression; Genes, Recessive; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Humans; Indoles; Lecithin Cholesterol Acyltransferase Deficiency; Lipoprotein-X; Male; Molecular Sequence Data; Monocytes; NF-kappa B; Phosphatidylcholines; Protein Kinase C; Pyrroles; Rats; Rats, Sprague-Dawley; RNA, Messenger; Staurosporine; Type C Phospholipases | 2001 |
Ca2+-antagonists inhibit the N-methyltransferase-dependent synthesis of phosphatidylcholine in the heart.
Topics: Animals; Binding Sites; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Diltiazem; Dose-Response Relationship, Drug; Heart; Male; Methylation; Methyltransferases; Mitochondria, Heart; Myocardium; Organ Culture Techniques; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; S-Adenosylmethionine; Sarcolemma; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Verapamil | 2001 |
Liposomal diltiazem HCl as ocular drug delivery system for glaucoma.
Topics: Animals; Antihypertensive Agents; Biological Availability; Chemistry, Pharmaceutical; Diltiazem; Drug Compounding; Drug Delivery Systems; Drug Liberation; Drug Stability; Glaucoma; Intraocular Pressure; Microscopy, Electron, Transmission; Phosphatidylcholines; Rabbits; Surface Properties; Unilamellar Liposomes | 2014 |